QYQining Yang

Qining Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qining Yang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Changyuan Wang

    Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China

    1 shared publication
  • Huijun Sun

    Department of Clinical Pharmacology College of Pharmacy, Dalian Medical University Dalian China

    1 shared publication
  • Kexin Liu

    Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China

    1 shared publication
  • Lifei Cai

    Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China

    1 shared publication
  • Qi Liu

    Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China

    1 shared publication
  • Qiang Meng

    Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China

    1 shared publication

Latest Publications

  • Open Access

    Activating the PGC‐1α/TERT Pathway by Catalpol Ameliorates Atherosclerosis via Modulating ROS Production, DNA Damage, and Telomere Function: Implications on Mitochondria and Telomere Link

    by Yukun Zhang, Changyuan Wang, Yue Jin, Qining Yang, Qiang Meng, Qi Liu, Yongguo Dai, Lifei Cai, Zhihao Liu, Kexin Liu, et al.

    Catalpol, an iridoid glucoside, has been found present in large quantities in the root of Rehmannia glutinosa L. and showed a strong antioxidant capacity in the previous study. In the present work, the protective effect of catalpol against AS via inhibiting oxidative stress, DNA damage, and telomere shortening was found in LDLr−/− mice. This study also shows that activation of the peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α)/telomerase reverse transcriptase (TERT) pathway, which is the new link between mitochondria and telomere, was involved in the protective effects of catalpol. Further, by using PGC‐1α or TERT siRNA in oxLDL‐treated macrophages, it is proved that catalpol reduced oxidative stress, telomere function, and related DNA damage at least partly through activating the PGC‐1α/TERT pathway. Moreover, dual luciferase activity assay‐validated catalpol directly enhanced PGC‐1α promoter activity. In conclusion, our study revealed that the PGC‐1α/TERT pathway might be a possible therapeutic target in AS and catalpol has highly favorable characteristics for the treatment of AS via modulating this pathway.